Ionis Pharmaceuticals, Inc. ( IONS) - Key Metrics
IONS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.62 | -$0.69 | $3.42 | $3.32 |
| 2026Q1 | $1.49 | -$0.56 | -$4.81 | -$4.94 |
| 2025Q4 | $1.25 | -$1.41 | -$0.85 | -$0.98 |
| 2025Q3 | $0.97 | -$0.80 | -$0.82 | -$0.84 |
| 2025Q3 | $0.97 | -$0.80 | -$0.82 | -$0.84 |
IONS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -28.73 |
| 2026Q1 | 0% | -33.52 |
| 2025Q4 | 0% | -14.03 |
| 2025Q3 | -17.09% | -22.99 |
| 2025Q3 | 0% | -20.44 |
IONS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 4.19% | 0% |
| 2026Q1 | -6.58% | 0% |
| 2025Q4 | -1.24% | 0% |
| 2025Q3 | -1.14% | 0.19% |
| 2025Q3 | -1.28% | 0% |
IONS
Price: $42.38
52 week price:
Earnings Per Share: -3.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 9.5 millionMarket Capitalization: 7.2 billion